Page last updated: 2024-09-05

bms204352 and Anxiety

bms204352 has been researched along with Anxiety in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahring, PK; Brown, WD; Hartz, BP; Korsgaard, MP; Mirza, NR; Strøbaek, D1

Other Studies

1 other study(ies) available for bms204352 and Anxiety

ArticleYear
Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 314, Issue:1

    Topics: Algorithms; Animals; Anti-Anxiety Agents; Anxiety; Ataxia; Behavior, Animal; Carbamates; Cell Line; Dose-Response Relationship, Drug; Emotions; Exploratory Behavior; Female; Hand Strength; Indoles; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Male; Membrane Potentials; Mice; Neurons; Oocytes; Patch-Clamp Techniques; Phenylenediamines; Potassium Channels, Voltage-Gated; Rats; Rats, Wistar; Receptors, GABA-A; RNA, Complementary; Stereoisomerism; Xenopus laevis

2005